Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Acting Treatment in Adolescents (LATA): A Randomised Open-label 2-arm 96 Week Trial in Virologically Suppressed HIV-1-positive Adolescents Aged 12-19 Years of Age in Sub-Saharan Africa

NCT05154747 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT05154747
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05154747 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Acting Treatment in Adolescents (LATA): A Randomised Open-label 2-arm 96 Week Trial in Virologically Suppressed HIV-1-positive Adolescents Aged 12-19 Years of Age in Sub-Saharan Africa
Lead sponsor
University College, London
Phase
Phase 3
Overall status
Unknown status
Start date
June 22, 2023
Completion date
March 31, 2026
Enrollment
476 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, hiv infections, hiv-1-infection, paediatric human immunodeficiency virus infection